Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability

References

• Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267–74
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9–20
   PubMed Web of Science ®Google Scholar
• Huber MM, Staubli AB, Kustedjo K, Gray MH, Shih J, Fraser SE, et al. Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem 1998; 9: 242–9
   PubMed Web of Science ®Google Scholar
• Modo M, Cash D, Mellodew K, Williams SC, Fraser SE, Meade TJ, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002; 17: 803–11
   PubMed Web of Science ®Google Scholar
• Liu W Frank JA Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 2008; (Epub ahead of print doi: 10/1016.j-erad.2008.09.0211).
   Google Scholar
• Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19: 1141–7
   PubMed Web of Science ®Google Scholar
• Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005; 234: 197–205
   PubMed Web of Science ®Google Scholar
• Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C. Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T. Rofo 2005; 177: 1151–63
   PubMedGoogle Scholar
• Hauger O, Frost EE, van HR, Deminiere C, Xue R, Delmas Y, Combe C, et al. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 2006; 238: 200–10
   PubMed Web of Science ®Google Scholar
• Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004; 233: 781–9
   PubMed Web of Science ®Google Scholar
• Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, et al. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007; 244: 514–23
   PubMed Web of Science ®Google Scholar
• Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001; 98: 7841–5
   PubMed Web of Science ®Google Scholar
• Ji JF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004; 22: 415–27
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells. 2006; 24: 1294–301
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Hammerstingl R, Schwarz W, Kummel S, Muller PK, Balzer T, et al. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996; 31: 696–708
   PubMedGoogle Scholar
• Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005; 237: 520–8
   PubMed Web of Science ®Google Scholar
• Wersebe A, Wiskirchen J, Decker U, Schick F, Dietz K, Muller-Schimpfle M, et al. Comparison of gadolinium-BOPTA and ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient. Invest Radiol 2006; 41: 264–71
   PubMedGoogle Scholar
• Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319–31
   PubMed Web of Science ®Google Scholar
• Lindl T, Lewandowski B, Schreyogg S, Staudte A. An evaluation of the in vitro cytotoxicities of 50 chemicals by using an electrical current exclusion method versus the neutral red uptake and MTT assays. Altern Lab Anim 2005; 33: 591–601
   PubMedGoogle Scholar
• Harville DA. Maximum likelihood approaches to variance component estimation and to related problems. J Am Stat Assc 1977; 72: 320–38
   Web of Science ®Google Scholar
• Berkson J. Why I prefer logits to probits. Biometrics 1951; 7: 327–39
   Web of Science ®Google Scholar
• Lang TA Sekic M How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers, 2nd edn. Philadelphia, PA: Am Coll Phys; 2006.
   Google Scholar
• Wu JC, Bengel FM, Gambhir SS. Cardiovascular molecular imaging. Radiology 2007; 244: 337–55
   PubMed Web of Science ®Google Scholar
• Sykova E, Jendelova P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 2007; 14: 1336–42
   PubMed Web of Science ®Google Scholar
• Jendelova P, Herynek V, Urdzikova L, Glogarova K, Kroupova J, Jersson B, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res. 2004; 76: 232–43
   PubMed Web of Science ®Google Scholar
• Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480–7
   PubMed Web of Science ®Google Scholar
• Dick AJ, Guttman MA, Raman VK, Peters DC, Pessanha BS, Hill JM, et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 2003; 108: 2899–904
   PubMed Web of Science ®Google Scholar
• Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108: 1009–14
   PubMed Web of Science ®Google Scholar
• Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838–46
   PubMed Web of Science ®Google Scholar
• Omidkhoda A, Mozdarani H, Movasaghpoor A, Poorfatolah A. Study of apoptosis in labeled mesenchymal stem cells with superparamagnetic iron oxide using neutral comet assay. Toxicol In Vitro 2007; 21: 1191–6
   PubMedGoogle Scholar
• Terrovitis JV, Bulte JW, Sarvananthan S, Crowe LA, Sarathchandra P, Batten P, et al. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds: relevance to tissue engineering. Tissue Eng 2006; 12: 2765–75
   PubMedGoogle Scholar
• Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004; 17: 513–17
   PubMed Web of Science ®Google Scholar
• Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 2004; 104: 3410–12
   PubMed Web of Science ®Google Scholar
• Schäfer R, Dominici M, Müller I, Dazzi F, Bieback K, Godthardt K, et al. Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29–30 September 2006, Tübingen, Germany. Cytotherapy 2007; 9: 397–405
   PubMed Web of Science ®Google Scholar
• Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed 2006; 19: 581–92
   PubMedGoogle Scholar
• Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005; 18: 553–9
   PubMed Web of Science ®Google Scholar
• Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. Mesenchymal stem cells utilize integrin beta1 not CXCR4 for myocardial migration and engraftment. Mol Biol Cell 2007; 18: 2873–82
   PubMed Web of Science ®Google Scholar
• Clarke E, McCann SR. Age dependent in vitro stromal growth. Bone Marrow Transplant 1989; 4: 596–7
   PubMedGoogle Scholar
• Minguell JJ, Martinez J. Growth pattern and function of bone marrow fibroblasts from normal and acute lymphoblastic leukemia patients. Exp Hematol 1983; 11: 522–6
   PubMed Web of Science ®Google Scholar
• Nagao T, Yamauchi K, Komatsuda M. Serial in vitro bone marrow fibroblast culture in human leukemia. Blood 1983; 61: 589–92
   PubMed Web of Science ®Google Scholar
• Reynolds M, McCann SR. A comparison between regimens containing chemotherapy alone (busulfan and cyclophosphamide) and chemotherapy (V. RAPID) plus total body irradiation on marrow engraftment following allogeneic bone marrow transplantation. Eur J Haematol 1989; 43: 314–20
   PubMedGoogle Scholar
• Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007; 243: 467–74
   PubMed Web of Science ®Google Scholar
• Aberle AM, Tablin F, Zhu J, Walker NJ, Gruenert DC, Nantz MH. A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity. Biochemistry 1998; 37: 6533–40
   PubMed Web of Science ®Google Scholar
• Hofland HE, Shephard L, Sullivan SM. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA 1996; 93: 7305–9
   PubMed Web of Science ®Google Scholar